Full-Time
Senior Viral Vector Bioprocess Engineer
Posted on 1/12/2023
Provides tools for designing and manufacturing biological cells
Senior
Dorchester, Boston, MA, USA
- 6+ years experience in upstream process development at a biopharma company or CDMO
- Bachelor's or Master's degree in Chemical Engineering, Bioengineering, Biotechnology, or a related field. PhD is preferred but not required
- Experience scaling-up an upstream mammalian cell culture process from benchtop to pilot or production-scale manufacturing
- Deep mammalian cell culture expertise in AAV or lentivirus production
- Experience working with shake flasks and small-scale automated bioreactors (e.g., AMBR15) in industry
- Knowledge of regulatory filing requirements
- Mastery of bioreactor operations including fed-batch and perfusion modes
- Experience with statistical tools/DOE for experimental design or process optimization
- Strong written and verbal communication skills
- Spearhead the roadmapping and development of mammalian bioreactor and upstream process infrastructure
- Design and execute bioreactor and shake flasks experiments to develop mammalian cell culture processes for production of viral vectors
- Lead upstream process scale-up with commercial partners
- Be a technical resource within the Synthetic Biology team by mentoring junior peers and adjacent technical roles
- Collaborate with the Automation and Software teams to develop automated systems for coordinating bioreactor runs and integrating process data into our computational platform
- Communicate ideas, data, and strategy with other technical members, executives, and commercial partners
- Organize and document experiments and data in an electronic lab notebook
Asimov's unique approach to biotechnology, integrating synthetic biology, computer-aided design, and machine learning, positions it as a leader in the design and manufacture of biologics and gene therapies. The company provides comprehensive support to its clients, offering both the tools for in-house cell line development and a service to create custom cell lines, demonstrating a commitment to flexibility and customer needs. Asimov's culture fosters interdisciplinary collaboration, driving technical advancements and enhancing its competitive edge in the biotech industry.
Company Stage
Series B
Total Funding
$204.7M
Headquarters
Boston, Massachusetts
Founded
2017